Mark L Hartman

4PUBLICATIONS
14CO-AUTHORS
Food properties (incl. characteristics and health benefits)Cancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 08, 2025
Appetite, eating attitudes, and eating behaviours during treatment with retatrutide in adults with type 2 diabetes: Results of a phase 2 study.

Chisom Kanu, Kristina S Boye, Jiat Ling Poon

|Jun 10, 2024
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial.

Arun J Sanyal, Lee M Kaplan, Juan P Frias

|May 20, 2024
Randomised clinical trial: Design of the SYNERGY-NASH phase 2b trial to evaluate tirzepatide as a treatment for metabolic dysfunction-associated steatohepatitis and modification of screening strategy to reduce screen failures.

Raj Vuppalanchi, Rohit Loomba, Arun J Sanyal

|Apr 16, 2020
Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes.

Mark L Hartman, Arun J Sanyal, Rohit Loomba

Pageof 1

Frequent Collaborators

2 joint publications

Deborah A Robins

2 joint publications

Arun J Sanyal

1 joint publications

Raj Vuppalanchi

1 joint publications

Rohit Loomba